Stemcells, Inc. Reports Second Quarter 2012 Financial Results and Provides Business Update
02 août 2012 16h33 HE
|
StemCells, Inc.
NEWARK, Calif., Aug. 2, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
StemCells, Inc. Announces Webcast to Discuss Second Quarter 2012 Financial Results and Business Update
31 juil. 2012 16h05 HE
|
StemCells, Inc.
NEWARK, Calif., July 31, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
StemCells, Inc. Broadens HuCNS-SC(R) Patent Portfolio With Key Patent in Japan
31 juil. 2012 09h00 HE
|
StemCells, Inc.
NEWARK, Calif., July 31, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced that the Japan Patent Office has granted to the Company Patent Number 5007003, titled "Enriched Central...
StemCells, Inc. Awarded $20 Million From the California Institute for Regenerative Medicine
26 juil. 2012 22h21 HE
|
StemCells, Inc.
Award to Fund IND-Enabling Activities for the Company's HuCNS-SC® Neural Stem Cells
in Cervical Spinal Cord Injury
Decision on Funding Alzheimer's Program Deferred to CIRM's September...
StemCells, Inc. Announces Its Human Neural Stem Cells Restore Memory in Models of Alzheimer's Disease
17 juil. 2012 08h30 HE
|
StemCells, Inc.
NEWARK, Calif., July 17, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), today announced preclinical data demonstrating that its proprietary human neural stem cells restored memory and...
StemCells, Inc. Initiates Phase I/II Clinical Trial in Dry Age-Related Macular Degeneration
21 juin 2012 09h00 HE
|
StemCells, Inc.
NEWARK, Calif., June 21, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced initiation of a Phase I/II clinical trial of the Company's proprietary HuCNS-SC® product candidate...
StemCells, Inc. Reports Positive Interim Safety Data From Spinal Cord Injury Trial
17 mai 2012 09h00 HE
|
StemCells, Inc.
NEWARK, Calif., May 17, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced completion of the first planned interim safety review of the Company's Phase I/II spinal cord injury...
StemCells, Inc. Reports First Quarter 2012 Financial Results and Provides Business Update
10 mai 2012 16h02 HE
|
StemCells, Inc.
NEWARK, Calif., May 10, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
StemCells, Inc. to Provide Progress Report on Spinal Cord Injury Trial at the Interdependence 2012 Global SCI Conference Co-Sponsored by the Rick Hansen Institute and the Rick Hansen Foundation
09 mai 2012 09h00 HE
|
StemCells, Inc.
NEWARK, Calif., May 9, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced that Armin Curt, MD, FRCPC, Professor and Chairman, Spinal Cord Injury Center at the University of Zurich,...
StemCells, Inc. Announces Webcast to Discuss First Quarter 2012 Financial Results and Business Update
07 mai 2012 09h00 HE
|
StemCells, Inc.
NEWARK, Calif., May 7, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...